Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2021-02-22 2021-02-22
Drug Identification Number 02408155 02408155
Brand name AURO-VALSARTAN HCT AURO-VALSARTAN HCT
Common or Proper name Valsartan HCT Valsartan HCT
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients VALSARTAN HYDROCHLOROTHIAZIDE VALSARTAN HYDROCHLOROTHIAZIDE
Strength(s) 320MG 25MG 320MG 25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30's 30's
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-02-18 2021-02-18
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments